IBDEI0K5 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9869,1,4,0)
 ;;=4^789.65
 ;;^UTILITY(U,$J,358.3,9869,1,5,0)
 ;;=5^Periumbilical Tenderness
 ;;^UTILITY(U,$J,358.3,9869,2)
 ;;=^303347
 ;;^UTILITY(U,$J,358.3,9870,0)
 ;;=789.66^^67^669^30
 ;;^UTILITY(U,$J,358.3,9870,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9870,1,4,0)
 ;;=4^789.66
 ;;^UTILITY(U,$J,358.3,9870,1,5,0)
 ;;=5^Epigastric Tenderness
 ;;^UTILITY(U,$J,358.3,9870,2)
 ;;=^303348
 ;;^UTILITY(U,$J,358.3,9871,0)
 ;;=070.1^^67^669^50
 ;;^UTILITY(U,$J,358.3,9871,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9871,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,9871,1,5,0)
 ;;=5^Hepatitis A
 ;;^UTILITY(U,$J,358.3,9871,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,9872,0)
 ;;=070.30^^67^669^51
 ;;^UTILITY(U,$J,358.3,9872,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9872,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,9872,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,9872,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,9873,0)
 ;;=070.32^^67^669^52
 ;;^UTILITY(U,$J,358.3,9873,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9873,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,9873,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,9873,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,9874,0)
 ;;=070.51^^67^669^53
 ;;^UTILITY(U,$J,358.3,9874,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9874,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,9874,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,9874,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,9875,0)
 ;;=070.54^^67^669^54
 ;;^UTILITY(U,$J,358.3,9875,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9875,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,9875,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,9875,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,9876,0)
 ;;=571.41^^67^669^55
 ;;^UTILITY(U,$J,358.3,9876,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9876,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,9876,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,9876,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,9877,0)
 ;;=571.1^^67^669^56
 ;;^UTILITY(U,$J,358.3,9877,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9877,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,9877,1,5,0)
 ;;=5^Hepatitis, ETOH Acute
 ;;^UTILITY(U,$J,358.3,9877,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,9878,0)
 ;;=070.59^^67^669^58
 ;;^UTILITY(U,$J,358.3,9878,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9878,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,9878,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,9878,2)
 ;;=^266631
 ;;^UTILITY(U,$J,358.3,9879,0)
 ;;=573.3^^67^669^57
 ;;^UTILITY(U,$J,358.3,9879,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9879,1,4,0)
 ;;=4^573.3
 ;;^UTILITY(U,$J,358.3,9879,1,5,0)
 ;;=5^Hepatitis, Other
 ;;^UTILITY(U,$J,358.3,9879,2)
 ;;=^56268
 ;;^UTILITY(U,$J,358.3,9880,0)
 ;;=555.9^^67^669^13
 ;;^UTILITY(U,$J,358.3,9880,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9880,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,9880,1,5,0)
 ;;=5^Crohn's Disease
 ;;^UTILITY(U,$J,358.3,9880,2)
 ;;=Crohn's Disease^29356
 ;;^UTILITY(U,$J,358.3,9881,0)
 ;;=787.91^^67^669^14
 ;;^UTILITY(U,$J,358.3,9881,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9881,1,4,0)
 ;;=4^787.91
 ;;^UTILITY(U,$J,358.3,9881,1,5,0)
 ;;=5^Diarrhea
 ;;^UTILITY(U,$J,358.3,9881,2)
 ;;=^33921
 ;;^UTILITY(U,$J,358.3,9882,0)
 ;;=562.11^^67^669^15
 ;;^UTILITY(U,$J,358.3,9882,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9882,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,9882,1,5,0)
 ;;=5^Diverticulitis, Colon
 ;;^UTILITY(U,$J,358.3,9882,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,9883,0)
 ;;=562.10^^67^669^16
 ;;^UTILITY(U,$J,358.3,9883,1,0)
 ;;=^358.31IA^5^2
